Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Stéphanie Bécourt"'
Autor:
Abel Cordoba, Benedicte Durand, Alexandre Escande, Sophie Taieb, Mariem Ben Haj Amor, Marie Cecile Le Deley, Andree Michel, Florence Le Tinier, Delphine Hudry, Carlos Martinez, Eric Leblanc, Stephanie Becourt, Cyril Abdedaim, Lucie Bresson, Eric Lartigau, Xavier Mirabel, Fabrice Narducci
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectivePelvic magnetic resonance imaging (MRI) is a key exam used for the initial assessment of loco-regional involvement of cervical cancer. In patients with locally advanced cervical cancer, MRI is used to evaluate the early response to radiochem
Externí odkaz:
https://doaj.org/article/3807379e9b244d51a91c9546c51d87f2
Autor:
François Cherifi, Sophie Lefevre Arbogast, Jonaz Font, Cyril Abdeddaim, Stephanie Becourt, Nicolas Penel, Elodie Coquan, Justine Lequesne, Yori Gidron, Florence Joly
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveIdentifying new modifiable prognostic markers is important for ovarian cancer (OC). Low parasympathic activity is associated with inflammation, oxidative stress and sympathetic nervous system activation. Previous studies reported that low va
Externí odkaz:
https://doaj.org/article/4fa3cc2ceb7f47df9f271880fc3dd061
Autor:
Nawale Hajjaji, Kathleen Lepoutre, Sarra Lakhdar, Stéphanie Bécourt, Charlotte Bellier, Emilie Kaczmarek, Antonin Broyelle, Sandrine Giscard, Eric Lartigau
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Background: Acute severe forms of COVID-19 infection are more likely in cancer patients and growing attention has been given to the persistent symptoms of the disease after severe COVID-19. However, mild illness is the dominant clinical presentation
Externí odkaz:
https://doaj.org/article/0fe39fbcbef54371b8d50cfeef4eee93
Autor:
Delphine Hudry, Solenn Le Guellec, Samuel Meignan, Stéphanie Bécourt, Camille Pasquesoone, Houssein El Hajj, Carlos Martínez-Gómez, Éric Leblanc, Fabrice Narducci, Sylvain Ladoire
Publikováno v:
Cancers. 14(21)
Epithelial ovarian cancers (EOC) are often diagnosed at an advanced stage with carcinomatosis and a poor prognosis. First-line treatment is based on a chemotherapy regimen combining a platinum-based drug and a taxane-based drug along with surgery. Mo
Summarize the writings published in the last 5 years on the management of surgery in the first line of treatment for advanced ovarian cancer.For patients with a significant tumor burden, the neoadjuvant chemotherapy therapy (NACT) with interval debul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19981c6cd3608c6dcf7c6beed0afb5f1
https://hdl.handle.net/10807/220106
https://hdl.handle.net/10807/220106
Autor:
Ben Meriem, Sophie Taïeb, Florence Le Tinier, Anne-Sophie Lemaire, Haj Amor, Cyril Abdeddaim, Charlotte Bellier, Fabrice Narducci, A. Cordoba, Emilie Kaczmarek, Valerie Chevalier-Evain, Eric Leblanc, A. Chevalier, Stéphanie Bécourt, Delphine Hudry
Publikováno v:
The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42dd08b10348b970cd56ce1b307a06e9
https://doi.org/10.1017/9781108582322.036
https://doi.org/10.1017/9781108582322.036
Autor:
Florence Ledoux, A de Roquancourt, Stéphanie Bécourt, Paul Blanc-Durand, A. Binasker, Luca Campedel, Caroline Cuvier, Sylvie Giacchetti, L. Teixeira, Marc Espié, C Gardnair
Publikováno v:
Cancer Research. 79:P5-17
Background Inflammatory breast cancers (IBC) particularly triple negative (TN) subtype have poor prognosis. There are few series reporting IBC outcome according to their immunohistochemical profile. We have already shown the efficiency of dose dense
Autor:
Stéphanie Bécourt, Florence Ledoux, Patrick Charveriat, Paul Blanc-Durand, Luis Augusto Teixeira, Jacqueline Lehmann-Che, E. Bourstyn, Sophie Guillerm, Cédric de Bazelaire, Luca Campedel, Anne de Roquancourt, Catherine Miquel, Caroline Cuvier, Sylvie Giacchetti, H. Hocini, Anne-Sophie Hamy, M. Espie, Asker Bin Asker
Publikováno v:
Cancers
Cancers, MDPI, 2020, 12 (9), pp.2657. ⟨10.3390/cancers12092657⟩
Cancers, Vol 12, Iss 2657, p 2657 (2020)
Volume 12
Issue 9
Cancers, MDPI, 2020, 12 (9), pp.2657. ⟨10.3390/cancers12092657⟩
Cancers, Vol 12, Iss 2657, p 2657 (2020)
Volume 12
Issue 9
Inflammatory breast cancers are very aggressive, and among them, triple negative breast cancer (TNBC) has the worst prognosis. While many studies have investigated the association between tumor-infiltrating lymphocytes (TIL) before neoadjuvant chemot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c67144cde11a07fc6652c48f0431a2a9
https://hal.sorbonne-universite.fr/hal-02953932
https://hal.sorbonne-universite.fr/hal-02953932
Autor:
Luis Augusto Teixeira, L. Doucet, Stéphanie Bécourt, F. Ledoux, O. Nguyen, Sandra Assoun, M. Espié, L. Campedel
Publikováno v:
Médecine Intensive Réanimation. 27:522-536
L’immunothérapie représente une avancée récente et importante en cancérologie. Les inhibiteurs de checkpoints immunitaires, ciblant les protéines PD-1, PD-L1 et CTLA-4, sont les thérapies les plus prometteuses et sont utilisés dans la prise
Publikováno v:
Imagerie de la Femme. 27:190-196
Resume Le cancer lobulaire infiltrant represente environ 10 % des cancers du sein. Les patientes se presentent souvent avec un stade plus avance au diagnostic. Son pronostic est cependant sensiblement identique a celui des cancers canalaires infiltra